27.00
+0.50
+(1.89%)
At close: April 17 at 4:00:01 PM EDT
27.77
+0.77
+(2.85%)
After hours: April 17 at 7:58:03 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | 35.8M | 38.15M | 153.48M | 173.25M |
| Low Estimate | 35.6M | 37.3M | 149.44M | 163.06M |
| High Estimate | 36M | 39M | 158M | 180.7M |
| Year Ago Sales | -- | -- | 125.59M | 153.48M |
| Sales Growth (year/est) | -- | -- | 22.20% | 12.88% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 |
|---|---|---|
| EPS Est. | -6.43 | -4.97 |
| EPS Actual | -3.5 | -2.89 |
| Difference | 2.93 | 2.08 |
| Surprise % | 45.53% | 41.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GRAL | -- | -- | -- | -- |
| S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/18/2025 |
| Initiated | Morgan Stanley: Equal-Weight | 11/27/2024 |
| Initiated | Guggenheim: Neutral | 10/17/2024 |
Related Tickers
ILMN Illumina, Inc.
71.20
-3.17%
GH Guardant Health, Inc.
44.97
-0.46%
WGS GeneDx Holdings Corp.
95.47
-2.86%
NTRA Natera, Inc.
148.08
-1.39%
EXAS Exact Sciences Corporation
41.58
-1.61%
TWST Twist Bioscience Corporation
36.80
-4.29%
MYGN Myriad Genetics, Inc.
7.64
-3.41%
CRL Charles River Laboratories International, Inc.
106.05
+1.73%
TMO Thermo Fisher Scientific Inc.
427.50
-2.13%
PSNL Personalis, Inc.
3.1900
-3.04%